GFAP and Alzheimer disease: Levels of GFAP in brain tissue are high in prodromal AD [34] and an increase in the levels of GFAP in cerebrospinal fluid (CSF) and plasma of AD patients is also detected in early stages, that peaks upon symptom onset [35].